← Back to headlines
Merck's stake in Evaxion and potential of AI-driven vaccine discovery
The article examines Merck & Company's investment in Evaxion A/S and its implications for validating the potential of artificial intelligence in vaccine discovery.
20 Aug, 22:06 — 20 Aug, 22:06
Sources
Showing 1 of 1 sources
